Year

Trump calls on Florida judge to help reinstate his YouTube account

Former President Donald Trump on Monday asked a Florida judge to issue a preliminary injunction in his case against YouTube that would compel the company to reinstate...

The Era of ‘Zuckbucks’ in Florida Election Administration Ends

The last of three Florida counties that took grant monies from a left-wing activist group funded by Facebook founder Mark Zuckerberg to help administer the 2020 elections has returned the remaining funds to the group after a new state law banned such grants, according to the Public Interest Legal Foundation.

Herschel Walker files to run for US Senate in Georgia

Former University of Georgia football legend Herschel Walker has filed to run for U.S. Senate in Georgia, becoming the most prominent Republican to line up to challenge incumbent Sen. Raphael Warnock (D-Ga.).

Democratic-led House authorizes $3.5 trillion of spending as national debt climbs to $29 trillion

Pelosi was ultimately able to secure yes votes from nine moderate House Democrats for the resolution which expands the social safety net in the U.S. with new federal programs.

What is really going on between Beijing and Washington in the South China Sea?

In today's polarised world, the situation in this hugely significant region of the Pacific is frequently portrayed as either Chinese expansionism or American imperialism. As ever, the truth of the matter is much more complicated.

Joe Biden Caves to Taliban: Sticks with August 31 Withdrawal Deadline

President Joe Biden on Tuesday caved to the Taliban and pledged to honor the August 31 withdrawal deadline for U.S. personnel in Afghanistan, Reuters reported.

Where the World’s Most Powerful Meet the World’s Money: World Economic Forum & BlackRock

Covid-19, climate change, and China—the shared focus of the World Economic Forum's "Great Reset" and BlackRock's "economic restart."

FDA Grants Full Approval of Pfizer Vaccine, Critics Blast Agency for Lack of Data, Scientific Debate

Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.

Latest news

- Advertisement -spot_img